Literature DB >> 18849618

The molecular interactions between filtered proteins and proximal tubular cells in proteinuria.

Richard J Baines1, Nigel J Brunskill.   

Abstract

Proteinuria is associated with progressive chronic kidney disease and poor cardiovascular outcomes. Exposure of proximal tubular epithelial cells to excess proteins leads to the development of proteinuric nephropathy with tubular atrophy, interstitial inflammation and scarring. Numerous signalling pathways are activated in proximal tubular epithelial cells under proteinuric conditions resulting in gene transcription, altered growth and the secretion of inflammatory and profibrotic mediators. Megalin, the proximal tubular scavenger receptor for filtered macromolecules, has intrinsic signalling functions and may also link albumin to growth factor receptor signalling via regulated intramembrane proteolysis. It now seems that endocytosis is not always a prerequisite for albumin-evoked alterations in proximal tubular cell phenotype. Recent evidence shows the presence of other potential receptors for proteins, such as the neonatal Fc receptor and CD36, in the proximal tubular epithelium. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849618     DOI: 10.1159/000161982

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  18 in total

1.  (Na+ + K+)-ATPase is a target for phosphoinositide 3-kinase/protein kinase B and protein kinase C pathways triggered by albumin.

Authors:  Diogo B Peruchetti; Ana Acacia S Pinheiro; Sharon S Landgraf; Mira Wengert; Christina M Takiya; William B Guggino; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

2.  Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Joshua S Speed; Carmen De Miguel; Eman Y Gohar; Tim M Townes; Abdullah Kutlar; Jennifer S Pollock; David M Pollock
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

3.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

4.  COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease.

Authors:  S Rangarajan; G Rezonzew; P Chumley; H Fatima; M Y Golovko; W Feng; P Hua; E A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-16

5.  Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.

Authors:  Melvin R Hayden; Javad Habibi; Adam Whaley-Connell; Dilek Sowers; Megan Johnson; Roger Tilmon; Deepika Jain; Carlos Ferrario; James R Sowers
Journal:  Am J Nephrol       Date:  2010-01-25       Impact factor: 3.754

6.  Tubular toxicity of proteinuria.

Authors:  Richard J Baines; Nigel J Brunskill
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

7.  Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006.

Authors:  Pietro Manuel Ferraro; Stefano Costanzi; Alessandro Naticchia; Antonio Sturniolo; Giovanni Gambaro
Journal:  BMC Public Health       Date:  2010-06-03       Impact factor: 3.295

8.  Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

Authors:  Hyun Ju Kim; Hamid Moradi; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08

9.  γ-Secretase inhibition promotes fibrotic effects of albumin in proximal tubular epithelial cells.

Authors:  C Slattery; Y Jang; W A Kruger; D H Hryciw; A Lee; P Poronnik
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Authors:  Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion de Jong; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.